Genedrive Share Discussion Threads

[daddy warbucks] 25/7/2024 16:50

You are too kind. It's great just using the filter button and makes it much easier to read.

[z1co] 25/7/2024 16:44

If NICE were not going to approve CYP2C19 then why would they say quote:

"NICE is working in partnership with colleagues at NHS England and NHS Improvement, to develop a resource to support the implementation which will publish alongside the final guidance."

That is the HUGE POSITIVE clue that they will APPROVE.

[z1co] 25/7/2024 16:37

Another cracking post from our host , NICE

[z1co] 25/7/2024 16:36

LOLOL

You're just a clown.

Are you keeping your imaginary short until Wednesday ,, hahahahaha

You should have shorted CLCO from 2p instead of going LONG and you would have made £100,000 , instead you've LOST over £100,000.

That's how clever you are

hahahahahahahah

[z1co] 25/7/2024 16:32

If NICE were not going to approve CYP2C19 then why would they say quote:

"NICE is working in partnership with colleagues at NHS England and NHS Improvement, to develop a resource to support the implementation which will publish alongside the final guidance."

That is the HUGE POSITIVE clue that they will APPROVE.

[z1co] 25/7/2024 16:31

More for these two clowns

On the basis of what NICE has said APPROVAL IS A CERTAINTY:

In addition to being dominant in cost effectiveness models, NICE recommends the Genedrive® as the point-of-care platform of choice for CYP2C19 genotyping strategies in the NHS. The decision was based on several differentiating features of the Genedrive® technology;

1) its greater coverage of genetic variants compared to the other point-of-care system assessed, permitting increased equitable access to healthcare across ethnic populations

2) no requirement for cold-chain storage logistics

3) its ability to integrate with patient electronic healthcare systems.

The UK's National Institute for Health and Care Excellence ("NICE") has recommended in draft guidance, that the Genedrive® CYP2C19-ID test should be used as the point-of-care test of choice in the NHS before clopidogrel administration in the management of IS and TIA patient

Resolution has now concluded, so we plan to publish as soon as we can. NICE is working in partnership with colleagues at NHS England and NHS Improvement, to develop a resource to support the implementation which will publish alongside the final guidance.

[premium beeks] 25/7/2024 16:23

So, you made it up then.Righty.

[z1co] 25/7/2024 16:21

If NICE were not going to approve CYP2C19 then why would they say quote:

"NICE is working in partnership with colleagues at NHS England and NHS Improvement, to develop a resource to support the implementation which will publish alongside the final guidance."

That is the HUGE POSITIVE clue that they will APPROVE.

If traders like Beeksy are too THICK to understand then it will their failure

[premium beeks] 25/7/2024 16:20

Z1co, I just want to check a few things, can you furnish me with a link please.

[z1co] 25/7/2024 16:17

Beeksy don't be so low

Any way are you keeping your imaginary short until Wednesday ?

LOLOL

[z1co] 25/7/2024 16:15

I'm not the only one buying there were 11.4m BUYs V 5.9m SELLs , that's a ratio of almost 2 to 1 in favour of buys

[premium beeks] 25/7/2024 16:15

AHH there you are Z1co.Have you a link to that article please.

[premium beeks] 25/7/2024 15:41

I note Z1co hasn't posted for an hour.Anyway, I'm upgrading my shower to a bath and heading off.Regards to the floor.

[atmysignal] 25/7/2024 15:29

There's a gap to fill at 2.80Look out below

[atmysignal] 25/7/2024 15:28

Looks like more pain tomorrow.Where's the bottom here!

[diggit180] 25/7/2024 15:06

Achievable but highly unlikely